1. Home
  2. JSPR vs CPZ Comparison

JSPR vs CPZ Comparison

Compare JSPR & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

N/A

Current Price

$1.17

Market Cap

34.7M

Sector

Health Care

ML Signal

N/A

Logo Calamos Long/Short Equity & Dynamic Income Trust

CPZ

Calamos Long/Short Equity & Dynamic Income Trust

N/A

Current Price

$13.71

Market Cap

297.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
JSPR
CPZ
Founded
2018
N/A
Country
United States
United States
Employees
64
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
34.7M
297.4M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
JSPR
CPZ
Price
$1.17
$13.71
Analyst Decision
Buy
Analyst Count
10
0
Target Price
$18.13
N/A
AVG Volume (30 Days)
257.4K
79.5K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$13.94
52 Week High
$7.19
$16.82

Technical Indicators

Market Signals
Indicator
JSPR
CPZ
Relative Strength Index (RSI) 35.08 19.46
Support Level $1.11 N/A
Resistance Level $1.44 $15.13
Average True Range (ATR) 0.07 0.23
MACD -0.01 -0.08
Stochastic Oscillator 6.67 4.31

Price Performance

Historical Comparison
JSPR
CPZ

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company that seeks to provide current income and risk-managed capital appreciation, with an investment objective to deliver total return through a combination of capital appreciation and current income. The Fund invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary, and others, and holds securities with a broad range of maturities, with the average term to maturity typically ranging from two to ten years. Managed assets represent the Fund's total assets, including any assets attributable to leverage that may be outstanding, minus total liabilities other than debt representing financial leverage.

Share on Social Networks: